Insilico Medicine included in the HKEX Tech 100 Index, drawing attention to opportunities in AI value chain
Business Announcement
Updates every hour. Last Updated: 28-Oct-2026 02:16 ET (28-Oct-2026 06:16 GMT/UTC)
Cambridge, Mass., September 3, 2026 — Insilico Medicine ("Insilico", HKEX: 3696), a clinical-stage drug discovery company powered by generative artificial intelligence (AI), announced that it will be included in the HKEX Tech 100 Index, following the methodology enhancements to broaden the exposure to “emerging technology trends, including opportunities across the AI value chain”, announced on 18 August 2026. All changes will be implemented after the market close on 11 September 2026 (Friday) and take effect on 14 September 2026 (Monday).
A new national survey of informal supporters of people with disability who have received NDIS-funded behaviour support services has found that families are often asked to choose behaviour support practitioners without enough information to judge their qualifications, experience or approach.
Bright light therapy lamps can improve sleep, activity levels and circadian rhythms of older adults in urban areas who have diminished exposure to natural light, a new study from the University of Surrey reports. Scientists believe such methods could provide a non-pharmacological and low-cost way to support healthy ageing in urban areas.
New research reveals a shared biology behind profound fatigue in five major illnesses - including long Covid and PTSD.
A new paper shows striking biological similarities between five major illnesses which until now have largely been viewed as separate disorders.
The findings suggest that chronic fatigue syndrome (also known as ME), long Covid, post-traumatic stress disorder (PTSD), rheumatoid arthritis and multiple sclerosis (MS) may be driven by common underlying mechanisms.
This is despite the conditions being triggered by different events - ranging from viral infections to psychological trauma or autoimmune responses.
Huntsman Cancer Institute marks a major construction milestone for its Vineyard campus that will bring hope and healing closer to patients and families in Utah County and the Mountain West.
Investigators from the Mass General Brigham Cancer Institute have found that adults with newly diagnosed acute myeloid leukemia (AML) receiving a less-intensive combination of azacitidine and venetoclax had more than twice as much time before treatment failed, the leukemia returned or worsened, or they died, compared with patients receiving intensive chemotherapy. Published in The New England Journal of Medicine, the findings could change the initial treatment approach for many patients with AML.
Roughly 10 percent of the American population lives with a neurodevelopmental condition, including autism spectrum disorders, ADHD, learning disorders, auditory and visual processing disorders, and more. Salk researchers uncover link between severe maternal illness during pregnancy and elevated risk of neurodevelopmental disorders in mice. Findings show maternal immune activation, as occurs during illness, leads to widespread epigenetic changes and altered frontal cortex in offspring.